Cannabis, COMT and psychotic experiences

British Journal of Psychiatry

Volumn 199, Issue 5, 2011, Pages 380-385

  Zammit, Stanley ^a,b   Owen, Michael J ^a   Evans, Jonathan ^b   Heron, Jon ^b   Lewis, Glyn ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS; CATECHOL METHYLTRANSFERASE; METHIONINE;

ARTICLE; COHORT ANALYSIS; GENOTYPE; HALLUCINATION; HOMOZYGOTE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PSYCHOSIS; QUESTIONNAIRE; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; CATECHOL O-METHYLTRANSFERASE; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HALLUCINATIONS; HAPLOTYPES; HUMANS; LONGITUDINAL STUDIES; MALE; MARIJUANA ABUSE; METHIONINE; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHOTIC DISORDERS; RISK; SELF REPORT; VALINE;

EID: 80655148027     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.111.091421     Document Type: Article

References (28)

1. Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M, et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007; 370: 319-28. (Pubitemid 47094993)
2. Clayton D, McKeigue PM. Epidemiological methods for studying genes and environmental factors in complex diseases. Lancet 2001; 358: 1356-60. (Pubitemid 33016504)
3. Munafo MR, Durrant C, Lewis G, Flint J. Gene x environment interactions at the serotonin transporter locus. Biol Psychiatry 2009; 65: 211-9.
4. Zammit S, Wiles N, Lewis G. The study of gene-environment interactions in psychiatry: limited gains at a substantial cost? Psychol Med 2010; 40: 711-6.
5. Chen J, Lipska BK, Halim N, Ma QD, Matsumoto M, Melhem S, et al. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 2004; 75: 807-21. (Pubitemid 39390488)
6. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996; 6: 243-50. (Pubitemid 26226317)
7. Munafo MR, Bowes L, Clark TG, Flint J. Lack of association of the COMT (Val158/108 Met) gene and schizophrenia: a meta-analysis of case-control studies. Mol Psychiatry 2005; 10: 765-70. (Pubitemid 41129049)
8. Okochi T, Ikeda M, Kishi T, Kawashima K, Kinoshita Y, Kitajima T, et al. Metaanalysis of association between genetic variants in COMT and schizophrenia: an update. Schizophr Res 2009; 110: 140-8.
9. Caspi A, Moffitt TE, Cannon M, McClay J, Murray R, Harrington H, et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene6environment interaction. Biol Psychiatry 2005; 57: 1117-27. (Pubitemid 40615773)
10. Costas J, Sanjuan J, Ramos-Rios R, Paz E, Agra S, Tolosa A, et al. Interaction between COMT haplotypes and cannabis in schizophrenia: a case-only study in two samples from Spain. Schizophr Res 2011; 127: 22-7.
11. van Winkel R. Family-based analysis of genetic variation underlying psychosis-inducing effects of cannabis: sibling analysis and proband follow-up. Arch Gen Psychiatry 2011; 68: 148-57.
12. Zammit S, Spurlock G, Williams H, Norton N, Williams N, O'Donovan MC, et al. Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: interactions with tobacco and cannabis use. Br J Psychiatry 2007; 191: 402-7. (Pubitemid 350069580)
13. Henquet C, Rosa A, Delespaul P, Papiol S, Fananas L, van Os J, et al. COMT ValMet moderation of cannabis-induced psychosis: a momentary assessment study of 'switching on' hallucinations in the flow of daily life. Acta Psychiatr Scand 2009; 119: 156-60.
14. Henquet C, Rosa A, Krabbendam L, Papiol S, Fananas L, Drukker M, et al. An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition. Neuropsychopharmacology 2006; 31: 2748-57. (Pubitemid 44764171)
15. Estrada G, Fatjo-Vilas M, Munoz MJ, Pulido G, Minano MJ, Toledo E, et al. Cannabis use and age at onset of psychosis: further evidence of interaction with COMT Val158Met polymorphism. Acta Psychiatr Scand 2011; 123: 485-92.
16. Horwood J, Salvi G, Thomas K, Duffy L, Gunnell D, Hollis C, et al. IQ and non-clinical psychotic symptoms in 12-year-olds: results from the ALSPAC birth cohort. Br J Psychiatry 2008; 193: 185-91.
17. Nackley AG, Shabalina SA, Tchivileva IE, Satterfield K, Korchynskyi O, Makarov SS, et al. Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science 2006; 314: 1930-3. (Pubitemid 46026115)
18. Office of PopulationCensus and Survey. Standard Occupational Classification. HMSO, 1991.
19. Wolke D, Woods S, Bloomfield L, Kerstadt L. The association between direct and rational bullying and behaviour problems among primary school children. J Child Psychol Psychiatry 2000; 41: 989-1002.
20. Angold A, Costello EJ, Messer SC, Pickles A, Winder F, Silver D. The development of a short questionnaire for use in epidemiological studies of depression in children and adolescents. J Method Psychiatr Res 1995; 5: 237-49. (Pubitemid 126764713)
21. Goodman R. The extended version of the Strengths and Difficulties Questionnaire as a guide to child psychiatric caseness and consequent burden. J Child Psychol Psychiatry 1999; 40: 791-9. (Pubitemid 29341355)
22. Kelleher I, Harley M, Murtagh A, Cannon M. Are screening instruments valid for psychotic-like experiences? A validation study of screening questions for psychotic-like experiences using in-depth clinical interview. Schizophr Bull 2011; 37: 362-9.
23. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-75. (Pubitemid 47330214)
24. Costas J, Sanjuan J, Ramos-Rios R, Paz E, Agra S, Tolosa A, et al. Interaction between COMT haplotypes and cannabis in schizophrenia: a case-only study in two samples from Spain. Schizophr Res; 127: 22-7.
25. Sanders AR, Duan J, Levinson DF, Shi J, He D, Hou C, et al. No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics. Am J Psychiatry 2008; 165: 497-506. (Pubitemid 351694293)
26. Callaway LK, McIntyre HD, O'Callaghan M, Williams GM, Najman JM, Lawlor DA. The association of hypertensive disorders of pregnancy with weight gain over the subsequent 21 years: findings from a prospective cohort study. Am J Epidemiol 2007; 166: 421-8. (Pubitemid 47216793)
27. Plewis I, Calderwoof L, Hawkes D, Nathan G. National Child Development Study and 1970 British Cohort Study Technical Report: Changes in the NCDS and BCS70 Populations and Samples over Time. Centre for Longitudinal Studies, Institute of Education, 2004.
28. Zammit S, Owen MJ, Lewis G. Misconceptions about gene-environment interactions in psychiatry. Evid Based Ment Health 2010; 13: 65-8.